§ 20-7-705. Licensing board rules
(a) A licensing board that licenses individuals with prescriptive authority shall adopt rules that are at least as stringent as the rules of the Arkansas State Medical Board concerning use of narcotics for the treatment of pain not associated with malignant or terminal illness. (b) A licensing board that licenses individuals who are authorized to […]
§ 20-7-706. Patient evaluation
A patient who is being treated with controlled substances for chronic nonmalignant pain shall be evaluated at least one (1) time every six (6) months by a physician who is licensed by the Arkansas State Medical Board.
§ 20-7-606. Confidentiality
(a) Prescription information submitted to the Department of Health under this subchapter is confidential and not subject to the Freedom of Information Act of 1967, § 25-19-101 et seq. (b) (1) The controlled substances database created in this subchapter and all information contained in the controlled substances database and any records maintained by the Department […]
§ 20-7-607. Providing prescription monitoring information
(a) (1) (A) (i) The Department of Health shall review the Prescription Drug Monitoring Program information, including without limitation a review to identify information that appears to indicate whether a person is obtaining prescriptions in a manner that may represent misuse or abuse of controlled substances based on prescribing criteria determined by the Secretary of […]
§ 20-7-408. Disposition of certain fees
(a) (1) Except as set forth in this subchapter, all fee revenues shall be treated as cash funds and shall not be deposited into the State Treasury, but shall be deposited as and when received into a bank or banks approved by the State Board of Health or the Secretary of the Department of Health […]
§ 20-7-608. Information exchange with other prescription drug monitoring programs
(a) The Department of Health may provide prescription monitoring information to federal prescription drug monitoring programs or other states’ prescription drug monitoring programs, and the information may be used by those programs consistent with this subchapter. (b) The department may request and receive prescription monitoring information from federal prescription drug monitoring programs or other states’ […]
§ 20-7-409. State Board of Health Public Health Laboratory Construction Fund
The proceeds of the loan other than amounts required to establish reserves, to pay interest on the loan for a period not to exceed one (1) year, or to pay costs of the loan and of issuing bonds, all of which shall be set forth in written directions executed by the Secretary of the Department […]
§ 20-7-609. Authority to contract
(a) The Department of Health may contract with another agency of this state or with a private vendor, as necessary, to ensure the effective operation of the Prescription Drug Monitoring Program. (b) A contractor shall be bound to comply with the provisions regarding confidentiality of prescription information as outlined in this subchapter and shall be […]
§ 20-7-410. Investment of funds
(a) All moneys held at any time in the State Board of Health Laboratory Revenue Fund and the State Board of Health Public Health Laboratory Construction Fund shall be invested and reinvested to the extent feasible, as directed by the Secretary of the Department of Health. (b) All moneys held in the State Board of […]
§ 20-7-610. Authority to seek funding
(a) The Department of Health may make application for, receive, and administer grant funding from public or private sources for the development, implementation, or enhancement of the Prescription Drug Monitoring Program. (b) A fee shall not be levied against practitioners for the purpose of funding or complying with the Prescription Drug Monitoring Program.